The first study involving a large cohort of cancer patients was conducted in 2010 by Cristòbal et al. which analyzed SETBP1 expression level in 192 AML cases, finding an overexpression in 53 patients (27.6%). The gene discussed is SETBP1; the disease is acute myeloid leukemia.